Psoriasis Clinical Trial

A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Palmoplantar Pustulosis

Summary

A study to evaluate the efficacy and safety, and pharmacokinetic (PK) profile of multiple doses of imsidolimab (ANB019) in adults with palmoplantar pustulosis (PPP)

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Clinically confirmed diagnosis of PPP
Disease duration of at least 6 months prior to screening
Present with active pustules on palms or/and soles at screening

Exclusion Criteria:

Any other ongoing inflammatory disease that interfere with the investigator's ability to evaluate the subject's response to therapy
History of recurrent or active/serious infection
Ongoing use of psoriasis prohibited medication

Other protocol-defined inclusion/exclusion criteria may apply

Study is for people with:

Psoriasis

Phase:

Phase 2

Estimated Enrollment:

59

Study ID:

NCT03633396

Recruitment Status:

Completed

Sponsor:

AnaptysBio, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 34 Locations for this study

See Locations Near You

University of Alabama at Birmingham
Birmingham Alabama, 35233, United States
Alliance Dermatology & MOHS Center, PC
Phoenix Arizona, 85032, United States
T. Joseph Raoof, MD, Inc.
Encino California, 91436, United States
Clinical Science Institute
Santa Monica California, 90405, United States
Next Phase Research Alliance
Fort Lauderdale Florida, 33316, United States
Ivetmar Medical Group, LLC
Miami Florida, 33155, United States
Riverchase Dermatology and Cosmetic Surgery
Pembroke Pines Florida, 33028, United States
Advanced Clinical Research Institute
Tampa Florida, 33607, United States
DFCRG
Indianapolis Indiana, 46250, United States
The Indiana Clinical Trials Center
Plainfield Indiana, 46168, United States
Kansas City Dermatology
Overland Park Kansas, 66215, United States
University of Michigan
Ann Arbor Michigan, 48109, United States
Washington University
Saint Louis Missouri, 63110, United States
Central Dermatology
Saint Louis Missouri, 63117, United States
WDC Cosmetic and Research PLLC
Wilmington North Carolina, 28405, United States
Ohio State University
Columbus Ohio, 43230, United States
Central Sooner Research
Norman Oklahoma, 73071, United States
Oregon Health & Science University (OHSU)
Portland Oregon, 97239, United States
Oregon Health & Science University
Portland Oregon, 97239, United States
Dermatology Treatment and Research Center
Dallas Texas, 75230, United States
Dr. Chin-ho Hong Medical, Inc.
Surrey British Columbia, , Canada
Lynderm Research Inc.
Markham Ontario, , Canada
Medicor Research, Inc.
Sudbury Ontario, , Canada
Dr. Isabelle Delorme, Inc.
Drummondville Quebec, , Canada
Dr. David Gratton Dermalogue, Inc.
Montréal Quebec, , Canada
Innovaderm Research, Inc.
Montréal Quebec, , Canada
Fachklinik Bad Bentheim, Dermatologisches Studienambulanz
Bad Bentheim , 48455, Germany
Klinische Forschung Berlin-Mitte GmbH
Berlin , 10117, Germany
ISA - Interdisciplinary Study Association GmbH
Berlin , 10789, Germany
Universitätsklinikum Bonn
Bonn , 53127, Germany
Klinische Forschung Hamburg GmbH
Hamburg , 20253, Germany
Mensing Derma Research GmbH
Hamburg , 22391, Germany
Klinische Forschung Schwerin GmbH
Schwerin , 19055, Germany
Centrum Badań Klinicznych PI-HOUSE Sp. z o. o.
Gdańsk , 80-54, Poland
Provita Sp. z o. o. Centrum Medyczne Angelius Provita
Katowice , 40-61, Poland
Klinika Dermatologii, Chorób Przenoszonych Drogą Płciową i Immunologii Klinicznej
Olsztyn , 10-22, Poland
Dermedic Jacek Zdybski
Ostrowiec Świętokrzyski , 27-40, Poland
Kliniczny Szpital Wojewódzki nr 1, Klinika Dermatologii
Rzeszów , 35-05, Poland
Laser Clinic s.c. Andrzej Królicki, Tomasz Kochanowski
Szczecin , 70-33, Poland
Cityclinic Przychodnia Lekarsko-Psychologiczna Matusiak Spółka Partnerska
Wrocław , 50-56, Poland
"DERMED" CENTRUM MEDYCZNE SP. z o.o.
Łódź , 90-26, Poland

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Phase:

Phase 2

Estimated Enrollment:

59

Study ID:

NCT03633396

Recruitment Status:

Completed

Sponsor:


AnaptysBio, Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider